Virpax Pharmaceuticals, Inc. (VRPX)
NASDAQ: VRPX · Real-Time Price · USD
0.567
-0.023 (-3.85%)
At close: Nov 22, 2024, 4:00 PM
0.500
-0.067 (-11.82%)
After-hours: Nov 22, 2024, 7:59 PM EST
Virpax Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3 | 4 | 7 | 40 | - | - | |
| Market Cap Growth | -63.78% | -48.56% | -81.86% | - | - | - | |
| Enterprise Value | 3 | -8 | -13 | -2 | - | - | |
| Last Close Price | 0.57 | 3.20 | 6.22 | 34.30 | - | - | |
| PB Ratio | -1.65 | 1.94 | 0.44 | 1.07 | - | - | |
| P/TBV Ratio | - | 1.94 | 0.44 | 1.07 | - | - | |
| Debt / Equity Ratio | - | - | - | - | -0.37 | -0.46 | |
| Quick Ratio | 0.01 | 1.19 | 6.14 | 17.65 | 0.01 | 0.01 | |
| Current Ratio | 0.13 | 1.25 | 6.36 | 18.96 | 0.02 | 0.02 | |
| Return on Equity (ROE) | -594.46% | -164.09% | -80.09% | -72.48% | - | - | |
| Return on Assets (ROA) | -87.78% | -55.20% | -38.71% | -37.54% | -1024.10% | -3675.30% | |
| Return on Capital (ROIC) | -262.94% | -87.37% | -42.42% | -43.15% | - | - | |
| Earnings Yield | -477.72% | -405.08% | -297.00% | -30.00% | - | - | |
| FCF Yield | -608.16% | -262.78% | -244.81% | -36.19% | - | - | |
| Buyback Yield / Dilution | -91.15% | -0.02% | -75.37% | -114.88% | -6.09% | -3.18% | |
| Total Shareholder Return | -91.15% | -0.02% | -75.37% | -114.88% | -6.09% | -3.18% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.